This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Covid-19

Clinical benefits of molnupiravir may extend beyond hospitalisation and death
Clinical benefits of molnupiravir may extend beyond hospitalisation and death
Study finds vitamin D status and COVID-19 diagnosis shows inconsistent associations
Study finds vitamin D status and COVID-19 diagnosis shows inconsistent associations
Hormone replacement therapy use linked to lower mortality risk from COVID-19
Hormone replacement therapy use linked to lower mortality risk from COVID-19
Fourth COVID-19 vaccination effectiveness drops after 10 weeks
Fourth COVID-19 vaccination effectiveness drops after 10 weeks
CT chest scans reveal fewer cases of pneumonia in breakthrough COVID-19 infections
CT chest scans reveal fewer cases of pneumonia in breakthrough COVID-19 infections
Oral aerosolised COVID-19 booster creates high antibody levels
Oral aerosolised COVID-19 booster creates high antibody levels
Scent dogs have comparable accuracy to PCR for detecting COVID-19 infected individuals
Scent dogs have comparable accuracy to PCR for detecting COVID-19 infected individuals
ENO Breathe programme for long COVID improves mental wellbeing and some aspects of breathlessness
ENO Breathe programme for long COVID improves mental wellbeing and some aspects of breathlessness
Study finds cancer patients with COVID-19 at greater risk of hospitalisation and death
Study finds cancer patients with COVID-19 at greater risk of hospitalisation and death
Androgen suppression with degarelix fails to improve outcomes in men hospitalised with COVID-19
Androgen suppression with degarelix fails to improve outcomes in men hospitalised with COVID-19
Fourth COVID-19 vaccination superior to third against adverse COVID-19-related outcomes
Fourth COVID-19 vaccination superior to third against adverse COVID-19-related outcomes
Study shows that BNT162b vaccination reduces risk of Omicron-associated hospitalisation by two-thirds in children aged 5-11 years
Study shows that BNT162b vaccination reduces risk of Omicron-associated hospitalisation by two-thirds in children aged 5-11 years


Popular articles

RSV vaccine meets primary endpoint in older adults
Meet the Expert : treatment-resistant depression
Bexotegrast improves lung function in idiopathic pulmonary fibrosis
Depression and poor mental health linked to higher incidence of CVD in young adults
Novel agent effective for haemophilia A




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora